US BROKER MOVES: SHEL upgraded at Morgan Stanley; PATH downgraded at Canaccord

Daily broker roundups of this kind rarely move the tape as a bundle; the names that travel are the ones where a rating change carries a thesis change rather than a target tweak.

Newsquawk StaffPublished On the live feed at 19 more headlines followed before this page went public
Newsquawk headlinesUTC

Canadian Full Time Employment Chg (Aug) -35.9K (Prev. 38.6K)

Canadian Participation Rate (Aug) 65.0% (Prev. 65.1%)

US BROKER MOVES: SHEL upgraded at Morgan Stanley; PATH downgraded at Canaccord

Citadel reportedly looking to buy US Shale oil production assets, according to sources

US Secretary of State Rubio will visit Colombia, Ecuador and Peru next week between 8th-10th September, the State Department says

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.

UPGRADES

  • W. P. Carey (WPC) upgraded from Underweight to Equal Weight; PT USD 80.00 at Barclays
  • Vodafone (VOD) upgraded from Sell to Buy; PT USD 20.93 (prev. USD 11.58) at Goldman Sachs
  • Shell (SHEL) upgraded from Equalweight to Overweight; PT USD 101.30 (prev. USD 81.60) at Morgan Stanley
  • Simmons First National (SFNC) upgraded from Neutral to Overweight; PT USD 27.50 (prev. USD 26.00) at Piper Sandler
  • Planet Labs (PL) upgraded from Sell to Neutral; PT USD 22.00 at New Street Research
  • Ormat Technologies (ORA) upgraded from Underperform to Market Perform; PT USD 112.00 at Bernstein SocGen Group
  • Freeport-McMoRan (FCX) upgraded from Hold to Buy; PT USD 75.00 at Freedom Broker

DOWNGRADES

  • Vale (VALE) downgraded from N/A to Sell; PT USD 12.00 (prev. USD 14.60) at Freedom Broker
  • UiPath (PATH) downgraded from Buy to Hold; PT USD 17.00 (prev. USD 15.00) at Canaccord
  • Ero Copper (ERO) downgraded from Buy to Hold; PT USD 43.20 (prev. USD 40.60) at Freedom Broker
  • Cal-Maine Foods (CALM) downgraded from Buy to Hold at StoneX
  • Ambarella (AMBA) downgraded from Buy to Hold; PT USD 70.00 at Craig-Hallum

INITIATIONS

  • Dianthus Therapeutics (DNTH) initiated Buy; PT USD 156.00 at Citi
  • Belite Bio (BLTE) initiated Buy at Canaccord
Context

The standout here is the Vodafone double upgrade from Sell to Buy with a near-doubling of the target at a major house, a reversal pattern that has historically drawn more follow-through than single-notch moves because it forces fast-money positioning to cover rather than merely add. The Shell upgrade to Overweight sits within the recurring pattern of integrated oil re-ratings that cluster when houses turn on the sector's capital returns and upstream mix, and peer targets at the other majors are the usual tell for whether it is a single-analyst view or the start of a sector-wide revision cycle. The two-notch moves in small and mid caps, and the clustered downgrades in copper and protein names, tend to be stock-specific unless they spread to the peer set. On past form, initiations at biotechs with large implied upside move the underlying only where liquidity allows. The follow-on worth noting is whether any of these calls are echoed by rival desks in coming sessions, since corroboration, not the initial note, is what has historically sustained re-ratings.

Related headlines

The whole workspace, free to try.

Try it free